Healthcare/Biotech
Apollo Hospitals demerger is a biz call taken for shareholders, says Suneeta Reddy; rules out family rift
Apollo Hospitals MD Suneeta Reddy says the group’s restructuring is about business strategy, not family dynamics, aiming to unlock value by separating hospital and pharmacy-digital units. She stresses close ties with sister Shobana Kamineni, outlines expansion in metros and Tier-II cities, focus on preventive care, tech-led growth and mentoring next generation of leaders.
- Biocon arm gets USFDA nod for generic Everolimus tablets
- Alembic Pharmaceuticals gets USFDA tentative nod for generic cancer treatment drug
- Delhi HC clears Zydus to sell biosimilar of BMS cancer drug Nivolumab
- Budget 2026: Pharma, med-tech companies seek PLI extension to cover APIs
- Aurobindo Pharma’s Dyrupeg faces Health Canada compliance notice
- Canadian pharmacy platform to offer India-sourced Ozempic to US patients
- Cardiac drugs log highest sales in 2025 as NCD cases surge
- Some food preservatives linked to higher cancer, diabetes risk
- Alkem Laboratories introduces hair growth support therapy kit
- Ayushman Bharat: UP cuts claim pendency sharply, speeds up hospital payments
- Sun Pharma Advanced Research to cut workforce by 40%
- Granules India gets USFDA tentative nod for generic ADHD treatment tablets
Ayushman Bharat: UP cuts claim pendency sharply, speeds up hospital payments
Sun Pharma Advanced Research to cut workforce by 40%
Granules India gets USFDA tentative nod for generic ADHD treatment tablets
Future diabetes care seen leaning towards GLP-1 drugs
Budget 2026: Volume to value - How India can get a quiet superpower
HC seeks Novo Nordisk's reply on Natco plea to revoke patent
Biotech
Biocon Biologics to introduce three new biosimilars for cancer treatment- Biocon Biologics gets global rights for biosimilar Adalimumab
- Centre weighs new law to regulate medical research
- Zydus Lifesciences introduces biosimilar to protect bone health in cancer patients
- ET Exclusive | Biologics merger with Biocon most value-accretive option: Kiran Mazumdar Shaw
Healthcare
Apollo Hospitals demerger is a biz call taken for shareholders, says Suneeta Reddy; rules out family rift- Some food preservatives linked to higher cancer, diabetes risk
- Ayushman Bharat: UP cuts claim pendency sharply, speeds up hospital payments
- HC seeks Novo Nordisk's reply on Natco plea to revoke patent
- Max Healthcare partners with The Learning Lab for advance healthcare capacity building, research
Pharmaceuticals

Delhi HC clears Zydus to sell biosimilar of BMS cancer drug Nivolumab
Budget 2026: Pharma, med-tech companies seek PLI extension to cover APIs
Aurobindo Pharma’s Dyrupeg faces Health Canada compliance notice
Canadian pharmacy platform to offer India-sourced Ozempic to US patients
Alkem Laboratories introduces hair growth support therapy kit
Must Watch
BACK TO TOP